Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
Open Access
- 1 July 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (7) , 1880-1882
- https://doi.org/10.2337/dc06-2257
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2007Diabetes Care, 2007
- Use of vascular risk‐modifying medications for diabetic patients differs between physician specialtiesDiabetic Medicine, 2006
- Indications for and utilization of ACE inhibitors in older individuals with diabetesJournal of General Internal Medicine, 2006
- Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and womenHeart, 2005
- Sex Disparities in Treatment of Cardiac Risk Factors in Patients With Type 2 DiabetesDiabetes Care, 2005
- Sex Differences in Quality of Health Care Related to Ischemic Heart Disease Prevention in Patients With DiabetesDiabetes Care, 2004
- Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosisCMAJ : Canadian Medical Association Journal, 2004
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesNew England Journal of Medicine, 2003
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998